Targeted Cancer Therapies World Congress 2010
Innovationa and opportunity for Pharma, Biotech, Healthcare and InvestorsSep 21,2010 - Sep 23,2010
SWISSOTEL, Zurich, Switzerland
-
Highlights
The 2010 Targeted Cancer Therapy World Congress is an executive-level, interactive conference experience tackling the biggest issues facing the oncology industry today.
The Targeted Cancer Therapy World Congress 2010 is an executive-level, interactive conference experience tackling the biggest issues facing the oncology industry today.In this new age of cancer drugs, this is the biggest opportunity for Big Pharma, regulators, imbursement representatives, academia and biotech to discuss the challenges and opportunities for targeted therapy in the wake of an era of blockbusters.
Event Reminder
- Registration Open
- Call for Papers
- Call for Speakers
- Receive GTM eblast updates
- Security Code:
Event Profile
- Theme: Innovationa and opportunity for Pharma, Biotech, Healthcare and Investors
- Sponsors: QIAGEN
- Speakers: Dr Jeremy Barton (Vice President Oncology R&D, Biogen Idec), Dr Margaret Beer (Senior Director and Head of Licensing and External Research, Merck & Co)
- Attendees: Big Pharma SVPs and Vps, Heads of Oncology, Medical Directors, Pre/Clinical Directors, Senior Scientists, Biotech/platform technology providers, Contract service providers, Regulators and government, Academics
Contact Details
- Contact person: Neil Darkes
- Event website: http://www.terrapinn.com/2010/tct/
- Phone: +44 (0) 207 092 1240
- Fax: +44 (0) 207 242 1508
Tags
Contact Organizer
